Intuitive Surgical EBITDA Margin 2012-2026 | ISRG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Intuitive Surgical (ISRG) over the last 10 years. The current EBITDA margin for Intuitive Surgical as of June 30, 2026 is .
| Intuitive Surgical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2026-06-30 | $11.03B | $4.25B | 38.55% |
| 2026-03-31 | $10.58B | $3.96B | 37.40% |
| 2025-12-31 | $10.06B | $3.62B | 36.00% |
| 2025-09-30 | $9.61B | $3.44B | 35.74% |
| 2025-06-30 | $9.15B | $3.18B | 34.78% |
| 2025-03-31 | $8.72B | $2.97B | 34.09% |
| 2024-12-31 | $8.35B | $2.85B | 34.10% |
| 2024-09-30 | $7.87B | $2.56B | 32.57% |
| 2024-06-30 | $7.57B | $2.44B | 32.23% |
| 2024-03-31 | $7.32B | $2.32B | 31.71% |
| 2023-12-31 | $7.12B | $2.22B | 31.19% |
| 2023-09-30 | $6.85B | $2.12B | 30.99% |
| 2023-06-30 | $6.66B | $2.04B | 30.57% |
| 2023-03-31 | $6.43B | $1.96B | 30.48% |
| 2022-12-31 | $6.22B | $1.97B | 31.68% |
| 2022-09-30 | $6.12B | $2.03B | 33.25% |
| 2022-06-30 | $5.96B | $2.07B | 34.67% |
| 2022-03-31 | $5.91B | $2.17B | 36.73% |
| 2021-12-31 | $5.71B | $2.16B | 37.88% |
| 2021-09-30 | $5.49B | $2.12B | 38.54% |
| 2021-06-30 | $5.16B | $1.93B | 37.36% |
| 2021-03-31 | $4.55B | $1.49B | 32.63% |
| 2020-12-31 | $4.36B | $1.34B | 30.81% |
| 2020-09-30 | $4.31B | $1.31B | 30.36% |
| 2020-06-30 | $4.36B | $1.38B | 31.76% |
| 2020-03-31 | $4.61B | $1.65B | 35.74% |
| 2019-12-31 | $4.48B | $1.59B | 35.50% |
| 2019-09-30 | $4.25B | $1.49B | 35.15% |
| 2019-06-30 | $4.04B | $1.42B | 35.21% |
| 2019-03-31 | $3.85B | $1.32B | 34.22% |
| 2018-12-31 | $3.73B | $1.33B | 35.79% |
| 2018-09-30 | $3.57B | $1.32B | 37.09% |
| 2018-06-30 | $3.46B | $1.28B | 37.08% |
| 2018-03-31 | $3.31B | $1.26B | 38.04% |
| 2017-12-31 | $3.14B | $1.17B | 37.37% |
| 2017-09-30 | $3.01B | $1.09B | 36.29% |
| 2017-06-30 | $2.88B | $1.07B | 37.17% |
| 2017-03-31 | $2.79B | $1.07B | 38.22% |
| 2016-12-31 | $2.71B | $1.05B | 38.90% |
| 2016-09-30 | $2.63B | $1.05B | 40.15% |
| 2016-06-30 | $2.53B | $1.00B | 39.42% |
| 2016-03-31 | $2.45B | $0.92B | 37.42% |
| 2015-12-31 | $2.39B | $0.86B | 35.89% |
| 2015-09-30 | $2.31B | $0.82B | 35.37% |
| 2015-06-30 | $2.27B | $0.77B | 33.66% |
| 2015-03-31 | $2.20B | $0.73B | 33.20% |
| 2014-12-31 | $2.13B | $0.65B | 30.63% |
| 2014-09-30 | $2.10B | $0.65B | 30.81% |
| 2014-06-30 | $2.05B | $0.67B | 32.55% |
| 2014-03-31 | $2.12B | $0.75B | 35.58% |
| 2013-12-31 | $2.27B | $0.96B | 42.25% |
| 2013-09-30 | $2.30B | $0.96B | 41.86% |
| 2013-06-30 | $2.34B | $1.00B | 42.70% |
| 2013-03-31 | $2.30B | $1.00B | 43.53% |
| 2012-12-31 | $2.18B | $0.94B | 42.96% |
| 2012-09-30 | $2.07B | $0.92B | 44.27% |
| 2012-06-30 | $1.98B | $0.88B | 44.33% |
| 2012-03-31 | $1.87B | $0.81B | 43.59% |
| 2011-12-31 | $1.76B | $0.76B | 43.46% |
| 2011-09-30 | $1.65B | $0.73B | 44.06% |
| 2011-06-30 | $1.55B | $0.67B | 43.50% |
| 2011-03-31 | $1.47B | $0.64B | 43.41% |
| 2010-12-31 | $1.41B | $0.61B | 43.38% |
| 2010-09-30 | $1.35B | $0.57B | 42.17% |
| 2010-06-30 | $1.28B | $0.54B | 42.01% |
| 2010-03-31 | $1.19B | $0.50B | 41.74% |
| 2009-12-31 | $1.05B | $0.41B | 39.16% |
| 2009-09-30 | $0.96B | $0.37B | 37.98% |
| 2009-06-30 | $0.92B | $0.34B | 37.51% |
| 2009-03-31 | $0.88B | $0.32B | 36.46% |
| 2008-12-31 | $0.88B | $0.34B | 38.40% |
| 2008-09-30 | $0.83B | $0.32B | 38.82% |
| 2008-06-30 | $0.75B | $0.29B | 38.25% |
| 2008-03-31 | $0.67B | $0.25B | 37.39% |
| 2007-12-31 | $0.60B | $0.22B | 36.50% |
| 2007-09-30 | $0.52B | $0.18B | 34.35% |
| 2007-06-30 | $0.46B | $0.15B | 32.61% |
| 2007-03-31 | $0.41B | $0.13B | 31.71% |
| 2006-12-31 | $0.37B | $0.12B | 31.37% |
| 2006-09-30 | $0.33B | $0.10B | 31.33% |
| 2006-06-30 | $0.30B | $0.10B | 33.33% |
| 2006-03-31 | $0.26B | $0.09B | 33.84% |
| 2005-12-31 | $0.23B | $0.08B | 33.33% |
| 2005-09-30 | $0.20B | $0.06B | 31.84% |
| 2005-06-30 | $0.18B | $0.05B | 27.43% |
| 2005-03-31 | $0.15B | $0.04B | 24.18% |
| 2004-12-31 | $0.14B | $0.03B | 20.29% |
| 2004-09-30 | $0.12B | $0.02B | 12.40% |
| 2004-06-30 | $0.11B | $0.01B | 6.42% |
| 2004-03-31 | $0.10B | $0.00B | 3.03% |
| 2003-12-31 | $0.09B | $0.00B | -1.10% |
| 2003-09-30 | $0.08B | $0.00B | -3.57% |
| 2003-06-30 | $0.08B | $-0.01B | -10.26% |
| 2003-03-31 | $0.08B | $-0.01B | -17.11% |
| 2002-12-31 | $0.07B | $-0.02B | -22.54% |
| 2002-09-30 | $0.07B | $-0.02B | -27.27% |
| 2002-06-30 | $0.06B | $-0.02B | -28.33% |
| 2002-03-31 | $0.05B | $-0.02B | -33.33% |
| 2001-12-31 | $0.05B | $-0.02B | -30.77% |
| 2001-09-30 | $0.05B | $-0.02B | -36.17% |
| 2001-06-30 | $0.04B | $-0.02B | -36.36% |
| 2001-03-31 | $0.04B | $-0.02B | -44.44% |
| 2000-12-31 | $0.03B | $-0.02B | -66.67% |
| 2000-06-30 | $0.01B | $-0.01B | -41.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $133.518B | $10.065B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Edwards Lifesciences (EW) | United States | $49.242B | 30.43 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| Alcon (ALC) | Switzerland | $33.505B | 20.78 |
| DexCom (DXCM) | United States | $31.955B | 33.21 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Globus Medical (GMED) | United States | $10.173B | 15.40 |
| Glaukos (GKOS) | United States | $10.092B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| Veracyte (VCYT) | United States | $3.313B | 27.11 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.36 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| OPKO Health (OPK) | United States | $1.164B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |